Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CODEXIS, INC. (CDXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 SC 13G/A BlackRock Inc. reports a 10.4% stake in CODEXIS INC
08/03/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/03/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Codexis Reports Second Quarter 2023 Financial Results Company Recently Announced Enhanced Strategic Focus and Portfolio Prioritization"
07/20/2023 8-K Quarterly results
06/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Amendment to Ninth Amended and Restated Certificate of Incorporation of Codexis, Inc",
"Codexis, Inc. 2023 Employee Stock Purchase Plan",
"Amendment to the Codexis, Inc. 2019 Incentive Award Plan"
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/04/2023 8-K Quarterly results
05/04/2023 POS EX Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/18/2023 144 Form 144 - Report of proposed sale of securities:
04/17/2023 144 Form 144 - Report of proposed sale of securities:
04/17/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/27/2023 10-K Annual Report for the period ended December 31, 2022
02/27/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
02/23/2023 8-K Quarterly results
Docs: "Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results Biotherapeutics Application of CodeEvolver® Validated by Recent Data Supporting the Potential for Three Upcoming Investigational New Drug Applications"
02/14/2023 SC 13G/A Nantahala Capital Management, LLC reports a 6.8% stake in Codexis, Inc.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 8-K Quarterly results
01/24/2023 SC 13G/A BlackRock Inc. reports a 9.4% stake in CODEXIS INC
01/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/18/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
12/20/2022 8-K Quarterly results
11/29/2022 8-K Quarterly results
11/04/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
10/03/2022 8-K Quarterly results
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "Codexis Reports Second Quarter 2022 Financial Results Total Revenue up 51% and Product Revenue up 135% YOY 2022 Total Revenue Guidance of $135M-$141M, Including Product Revenues of $112M-$118M Codexis Reports Second Quarter 2022 Financial Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy